Fig. 1 · Structure
Documents & Downloads
Efdamrofusp alfa
Fusion Protein
Efdamrofusp alfa is a bispecific fusion protein designed to neutralize both VEGF isoforms and complement components C3b and C4b. Its dual action makes it particularly relevant for research into neovascular age-related macular degeneration (nAMD) and other ocular conditions associated with complement activation. Efdamrofusp alfa serves as a valuable tool for understanding the underlying mechanisms of ocular diseases and developing targeted therapeutic strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2375661-82-6 |
| Applications | Fusion Protein |
| Molecular Weight | 140.4 kDa |
| Synonyms | IBI302 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.